Human Phenotype Ontology 
Grandparent Node:
expand
Anorectal anomaly (HP:0012732)help
Parent Node:
expand
Abnormality of the anus (HP:0004378)help
..Starting node
..expand
Anal atresia (HP:0002023)help
Term ID: 2023
Name: Anal atresia
Synonym: Absent anus; Imperforate anus
Definition: Congenital absence of the anus, i.e., the opening at the bottom end of the intestinal tract.
Comments:
Reference: HP:0002023
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAnal canal neoplasm (HP:0030437) help
..expandAnal fissure (HP:0012390) help
..expandAnal fistula (HP:0010447) help
..expandAnal margin neoplasm (HP:0030440) help
..expandAnal mucosal leukoplakia (HP:0005212) help
..expandAnal stenosis (HP:0002025) help
..expandEctopic anus (HP:0004397) help
..expandPerianal abscess (HP:0009789) help
..expandPerianal dermatitis (HP:0011131) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002023HP:0002023Anal atresia0ABL1 CL E G H2576OMIM:617602Congenital heart defects and skeletal malformations syndromeHP:0040284 - Very rare51
HP:0002023HP:0002023Anal atresia0AMER1 CL E G H13928526837OMIM:300373Osteopathia striata with cranial sclerosisHP:0040284 - Very rare34
HP:0002023HP:0002023Anal atresia0AR CL E G H367644ORPHA:95706Non-syndromic posterior hypospadiasHP:0040283 - Occasional125
HP:0002023HP:0002023Anal atresia0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional1
HP:0002023HP:0002023Anal atresia0B3GLCT CL E G H14517320207ORPHA:709Peters plus syndromeHP:0040283 - Occasional36
HP:0002023HP:0002023Anal atresia0BCOR CL E G H5488020893OMIM:309800Microphthalmia, syndromic 1.101
HP:0002023HP:0002023Anal atresia0BRCA1 CL E G H6721100ORPHA:84Fanconi anemiaHP:0040283 - Occasional5769
HP:0002023HP:0002023Anal atresia0BRCA2 CL E G H6751101ORPHA:84Fanconi anemiaHP:0040283 - Occasional7642
HP:0002023HP:0002023Anal atresia0BRCA2 CL E G H6751101OMIM:605724Fanconi anemia, complementation group D17642
HP:0002023HP:0002023Anal atresia0BRIP1 CL E G H8399020473ORPHA:84Fanconi anemiaHP:0040283 - Occasional1086
HP:0002023HP:0002023Anal atresia0CAPN15 CL E G H665011182OMIM:619318OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME; OGIN
HP:0002023HP:0002023Anal atresia0CCDC22 CL E G H2895228909ORPHA:73C syndromeHP:0040283 - Occasional33
HP:0002023HP:0002023Anal atresia0CCNQ CL E G H9200228434ORPHA:140952Syndactyly-telecanthus-anogenital and renal malformations syndromeHP:0040281 - Very frequent7
HP:0002023HP:0002023Anal atresia0CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent38
HP:0002023HP:0002023Anal atresia0CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002023HP:0002023Anal atresia0CDC45 CL E G H83181739OMIM:617063Meier-Gorlin syndrome 7.9
HP:0002023HP:0002023Anal atresia0CDH1 CL E G H9991748ORPHA:1997Blepharo-cheilo-odontic syndromeHP:0040283 - Occasional1003
HP:0002023HP:0002023Anal atresia0CDH1 CL E G H9991748OMIM:119580Blepharocheilodontic syndrome 1HP:0040283 - Occasional1003
HP:0002023HP:0002023Anal atresia0CEP120 CL E G H15324126690OMIM:616300Short-Rib thoracic dysplasia 13 with or without polydactyly.7
HP:0002023HP:0002023Anal atresia0CHD7 CL E G H5563620626OMIM:214800Charge syndrome.515
HP:0002023HP:0002023Anal atresia0CHRM3 CL E G H11311952OMIM:100100Prune belly syndrome.4
HP:0002023HP:0002023Anal atresia0CHRM3 CL E G H11311952ORPHA:2970Prune belly syndromeHP:0040283 - Occasional4
HP:0002023HP:0002023Anal atresia0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional6
HP:0002023HP:0002023Anal atresia0COX7B CL E G H13492291OMIM:309801Microphthalmia, syndromic 7.6
HP:0002023HP:0002023Anal atresia0CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0002023HP:0002023Anal atresia0CTNND1 CL E G H15002515ORPHA:1997Blepharo-cheilo-odontic syndromeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0DACT1 CL E G H5133917748ORPHA:63260CraniorachischisisHP:0040283 - Occasional2
HP:0002023HP:0002023Anal atresia0DACT1 CL E G H5133917748ORPHA:857Townes-Brocks syndromeHP:0040281 - Very frequent2
HP:0002023HP:0002023Anal atresia0DACT1 CL E G H5133917748OMIM:617466Townes-Brocks syndrome 2.2
HP:0002023HP:0002023Anal atresia0DCHS1 CL E G H864213681OMIM:601390Van maldergem syndrome 1.27
HP:0002023HP:0002023Anal atresia0DPYS CL E G H18073013OMIM:222748Dihydropyrimidinuria.44
HP:0002023HP:0002023Anal atresia0DYNC2H1 CL E G H796592962OMIM:613091Asphyxiating thoracic dystrophy 3HP:0040283 - Occasional304
HP:0002023HP:0002023Anal atresia0DYNC2H1 CL E G H796592962ORPHA:93271Short rib-polydactyly syndrome, Verma-Naumoff typeHP:0040283 - Occasional304
HP:0002023HP:0002023Anal atresia0DYNC2I1 CL E G H5511221862ORPHA:93271Short rib-polydactyly syndrome, Verma-Naumoff typeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0DYNC2I2 CL E G H8989128296ORPHA:93271Short rib-polydactyly syndrome, Verma-Naumoff typeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0EHMT1 CL E G H7981324650ORPHA:261652Kleefstra syndrome due to a point mutationHP:0040284 - Very rare223
HP:0002023HP:0002023Anal atresia0EMC1 CL E G H2306528957OMIM:616875Cerebellar atrophy, visual impairment, and psychomotor retardation5
HP:0002023HP:0002023Anal atresia0EMC1 CL E G H2306528957ORPHA:480898Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndromeHP:0040283 - Occasional5
HP:0002023HP:0002023Anal atresia0EPCAM CL E G H407211529ORPHA:92050Congenital tufting enteropathyHP:0040284 - Very rare170
HP:0002023HP:0002023Anal atresia0ERCC4 CL E G H20723436ORPHA:84Fanconi anemiaHP:0040283 - Occasional158
HP:0002023HP:0002023Anal atresia0EXTL3 CL E G H21373518OMIM:617425Immunoskeletal dysplasia with neurodevelopmental abnormalitiesHP:0040283 - Occasional3
HP:0002023HP:0002023Anal atresia0FANCA CL E G H21753582ORPHA:84Fanconi anemiaHP:0040283 - Occasional340
HP:0002023HP:0002023Anal atresia0FANCB CL E G H21873583ORPHA:84Fanconi anemiaHP:0040283 - Occasional58
HP:0002023HP:0002023Anal atresia0FANCB CL E G H21873583OMIM:314390VACTERL association, X-linked.58
HP:0002023HP:0002023Anal atresia0FANCB CL E G H21873583ORPHA:3412VACTERL with hydrocephalusHP:0040281 - Very frequent58
HP:0002023HP:0002023Anal atresia0FANCC CL E G H21763584ORPHA:84Fanconi anemiaHP:0040283 - Occasional410
HP:0002023HP:0002023Anal atresia0FANCD2 CL E G H21773585ORPHA:84Fanconi anemiaHP:0040283 - Occasional147
HP:0002023HP:0002023Anal atresia0FANCE CL E G H21783586ORPHA:84Fanconi anemiaHP:0040283 - Occasional73
HP:0002023HP:0002023Anal atresia0FANCF CL E G H21883587ORPHA:84Fanconi anemiaHP:0040283 - Occasional87
HP:0002023HP:0002023Anal atresia0FANCG CL E G H21893588ORPHA:84Fanconi anemiaHP:0040283 - Occasional73
HP:0002023HP:0002023Anal atresia0FANCI CL E G H5521525568ORPHA:84Fanconi anemiaHP:0040283 - Occasional157
HP:0002023HP:0002023Anal atresia0FANCL CL E G H5512020748ORPHA:84Fanconi anemiaHP:0040283 - Occasional53
HP:0002023HP:0002023Anal atresia0FANCL CL E G H5512020748OMIM:614083Fanconi anemia, complementation group LHP:0040283 - Occasional53
HP:0002023HP:0002023Anal atresia0FANCM CL E G H5769723168ORPHA:84Fanconi anemiaHP:0040283 - Occasional107
HP:0002023HP:0002023Anal atresia0FGFR2 CL E G H22633689ORPHA:93259Pfeiffer syndrome type 2HP:0040283 - Occasional175
HP:0002023HP:0002023Anal atresia0FGFR2 CL E G H22633689ORPHA:93260Pfeiffer syndrome type 3HP:0040283 - Occasional175
HP:0002023HP:0002023Anal atresia0FKRP CL E G H7914717997OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.157
HP:0002023HP:0002023Anal atresia0FKTN CL E G H22183622OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.184
HP:0002023HP:0002023Anal atresia0FOXF1 CL E G H22943809OMIM:265380Alveolar capillary dysplasia with misalignment of pulmonary veins61
HP:0002023HP:0002023Anal atresia0FOXF1 CL E G H22943809ORPHA:210122Congenital alveolar capillary dysplasiaHP:0040283 - Occasional61
HP:0002023HP:0002023Anal atresia0FRAS1 CL E G H8014419185ORPHA:2052Fraser syndromeHP:0040282 - Frequent353
HP:0002023HP:0002023Anal atresia0FREM2 CL E G H34164025396ORPHA:2052Fraser syndromeHP:0040282 - Frequent263
HP:0002023HP:0002023Anal atresia0FUZ CL E G H8019926219ORPHA:3027Caudal regression sequenceHP:0040282 - Frequent3
HP:0002023HP:0002023Anal atresia0GATA1 CL E G H26234170OMIM:190685Down syndrometrisomy 21, included.29
HP:0002023HP:0002023Anal atresia0GDF3 CL E G H95734218ORPHA:2345Isolated Klippel-Feil syndromeHP:0040283 - Occasional7
HP:0002023HP:0002023Anal atresia0GDF6 CL E G H3922554221ORPHA:2345Isolated Klippel-Feil syndromeHP:0040283 - Occasional64
HP:0002023HP:0002023Anal atresia0GLI3 CL E G H27374319OMIM:146510Pallister-Hall syndrome270
HP:0002023HP:0002023Anal atresia0GLI3 CL E G H27374319ORPHA:672Pallister-Hall syndromeHP:0040282 - Frequent270
HP:0002023HP:0002023Anal atresia0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional8
HP:0002023HP:0002023Anal atresia0GPC3 CL E G H27194451OMIM:312870Simpson-golabi-behmel syndrome, type 173
HP:0002023HP:0002023Anal atresia0GPC4 CL E G H22394452OMIM:312870Simpson-golabi-behmel syndrome, type 1
HP:0002023HP:0002023Anal atresia0GRIP1 CL E G H2342618708ORPHA:2052Fraser syndromeHP:0040282 - Frequent80
HP:0002023HP:0002023Anal atresia0HCCS CL E G H30524837OMIM:309801Microphthalmia, syndromic 7.11
HP:0002023HP:0002023Anal atresia0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional3
HP:0002023HP:0002023Anal atresia0HOXD13 CL E G H32395136ORPHA:887VACTERL/VATER associationHP:0040281 - Very frequent25
HP:0002023HP:0002023Anal atresia0HSPA9 CL E G H33135244OMIM:616854Even-Plus syndrome6
HP:0002023HP:0002023Anal atresia0ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0002023HP:0002023Anal atresia0IFT80 CL E G H5756029262ORPHA:93271Short rib-polydactyly syndrome, Verma-Naumoff typeHP:0040283 - Occasional65
HP:0002023HP:0002023Anal atresia0INTU CL E G H2715229239OMIM:617925Short-Rib thoracic dysplasia 20 with polydactyly
HP:0002023HP:0002023Anal atresia0IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent4
HP:0002023HP:0002023Anal atresia0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional2
HP:0002023HP:0002023Anal atresia0KDM6A CL E G H740312637OMIM:147920Kabuki syndrome 1.53
HP:0002023HP:0002023Anal atresia0KIF7 CL E G H37465430497OMIM:200990Acrocallosal syndrome.167
HP:0002023HP:0002023Anal atresia0KMT2C CL E G H5850813726ORPHA:261652Kleefstra syndrome due to a point mutationHP:0040284 - Very rare99
HP:0002023HP:0002023Anal atresia0KMT2D CL E G H80857133OMIM:147920Kabuki syndrome 1.660
HP:0002023HP:0002023Anal atresia0LARGE1 CL E G H92156511OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.136
HP:0002023HP:0002023Anal atresia0LONP1 CL E G H93619479OMIM:600373CODAS syndrome8
HP:0002023HP:0002023Anal atresia0MAD2L2 CL E G H104596764ORPHA:84Fanconi anemiaHP:0040283 - Occasional1
HP:0002023HP:0002023Anal atresia0MAMLD1 CL E G H100462568ORPHA:95706Non-syndromic posterior hypospadiasHP:0040283 - Occasional5
HP:0002023HP:0002023Anal atresia0MED12 CL E G H996811957ORPHA:93932FG syndrome type 1HP:0040283 - Occasional228
HP:0002023HP:0002023Anal atresia0MED12 CL E G H996811957OMIM:305450Opitz-Kaveggia syndrome.228
HP:0002023HP:0002023Anal atresia0MEOX1 CL E G H42227013ORPHA:2345Isolated Klippel-Feil syndromeHP:0040283 - Occasional5
HP:0002023HP:0002023Anal atresia0MID1 CL E G H42817095ORPHA:2745Opitz GBBB syndromeHP:0040283 - Occasional57
HP:0002023HP:0002023Anal atresia0MID1 CL E G H42817095OMIM:300000Opitz gbbb syndrome, type I.57
HP:0002023HP:0002023Anal atresia0MKKS CL E G H81957108ORPHA:2473McKusick-Kaufman syndromeHP:0040283 - Occasional69
HP:0002023HP:0002023Anal atresia0MKKS CL E G H81957108OMIM:236700Mckusick-Kaufman syndrome.69
HP:0002023HP:0002023Anal atresia0MKS1 CL E G H549037121OMIM:249000Meckel syndrome 1.127
HP:0002023HP:0002023Anal atresia0MNX1 CL E G H31104979OMIM:176450Currarino syndrome.17
HP:0002023HP:0002023Anal atresia0MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002023HP:0002023Anal atresia0MYCN CL E G H46137559ORPHA:391641Feingold syndrome type 1HP:0040284 - Very rare35
HP:0002023HP:0002023Anal atresia0NAA10 CL E G H826018704OMIM:309800Microphthalmia, syndromic 1.23
HP:0002023HP:0002023Anal atresia0NBN CL E G H46837652ORPHA:647Nijmegen breakage syndromeHP:0040281 - Very frequent706
HP:0002023HP:0002023Anal atresia0NBN CL E G H46837652OMIM:251260Nijmegen breakage syndrome.706
HP:0002023HP:0002023Anal atresia0NDUFB11 CL E G H5453920372OMIM:309801Microphthalmia, syndromic 7.3
HP:0002023HP:0002023Anal atresia0NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent7
HP:0002023HP:0002023Anal atresia0NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent11
HP:0002023HP:0002023Anal atresia0PALB2 CL E G H7972826144ORPHA:84Fanconi anemiaHP:0040283 - Occasional1349
HP:0002023HP:0002023Anal atresia0PERCC1 CL E G H10537104552293ORPHA:92050Congenital tufting enteropathyHP:0040284 - Very rare
HP:0002023HP:0002023Anal atresia0PIGN CL E G H235568967ORPHA:2059Fryns syndromeHP:0040283 - Occasional37
HP:0002023HP:0002023Anal atresia0PIGN CL E G H235568967ORPHA:280633Multiple congenital anomalies-hypotonia-seizures syndromeHP:0040283 - Occasional37
HP:0002023HP:0002023Anal atresia0PIGN CL E G H235568967OMIM:614080Multiple congenital anomalies-hypotonia-seizures syndrome 137
HP:0002023HP:0002023Anal atresia0PIGO CL E G H8472023215OMIM:614749Hyperphosphatasia with mental retardation syndrome 284
HP:0002023HP:0002023Anal atresia0PITX2 CL E G H53089005OMIM:180500Axenfeld-rieger syndrome, type 1.51
HP:0002023HP:0002023Anal atresia0POMT1 CL E G H105859202OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.213
HP:0002023HP:0002023Anal atresia0POMT2 CL E G H2995419743OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.221
HP:0002023HP:0002023Anal atresia0PPP2R3C CL E G H5501217485OMIM:618419Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy.
HP:0002023HP:0002023Anal atresia0PQBP1 CL E G H100849330OMIM:309500Renpenning syndrome28
HP:0002023HP:0002023Anal atresia0PQBP1 CL E G H100849330ORPHA:93950X-linked intellectual disability, Sutherland-Haan typeHP:0040283 - Occasional28
HP:0002023HP:0002023Anal atresia0PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0002023HP:0002023Anal atresia0RAD51 CL E G H58889817ORPHA:84Fanconi anemiaHP:0040283 - Occasional9
HP:0002023HP:0002023Anal atresia0RAD51 CL E G H58889817OMIM:617244Fanconi anemia, complementation group R.9
HP:0002023HP:0002023Anal atresia0RAD51C CL E G H58899820ORPHA:84Fanconi anemiaHP:0040283 - Occasional391
HP:0002023HP:0002023Anal atresia0RAD51C CL E G H58899820OMIM:613390Fanconi anemia, complementation group O.391
HP:0002023HP:0002023Anal atresia0RECQL4 CL E G H94019949ORPHA:1225Baller-Gerold syndromeHP:0040283 - Occasional445
HP:0002023HP:0002023Anal atresia0RECQL4 CL E G H94019949OMIM:218600Baller-Gerold syndrome.445
HP:0002023HP:0002023Anal atresia0RFWD3 CL E G H5515925539ORPHA:84Fanconi anemiaHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0RIPK4 CL E G H54101496OMIM:263650Popliteal pterygium syndrome, Bartsocas-Papas type 169
HP:0002023HP:0002023Anal atresia0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0RSPO2 CL E G H34041928583ORPHA:3301Tetraamelia-multiple malformations syndromeHP:0040282 - Frequent
HP:0002023HP:0002023Anal atresia0SALL1 CL E G H629910524ORPHA:857Townes-Brocks syndromeHP:0040281 - Very frequent124
HP:0002023HP:0002023Anal atresia0SALL1 CL E G H629910524OMIM:107480Townes-Brocks syndrome 1124
HP:0002023HP:0002023Anal atresia0SALL4 CL E G H5716715924OMIM:607323Duane-Radial ray syndrome.86
HP:0002023HP:0002023Anal atresia0SALL4 CL E G H5716715924OMIM:147750Ivic syndrome86
HP:0002023HP:0002023Anal atresia0SALL4 CL E G H5716715924ORPHA:2307IVIC syndromeHP:0040283 - Occasional86
HP:0002023HP:0002023Anal atresia0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0SIN3A CL E G H2594219353ORPHA:9406515q24 microdeletion syndromeHP:0040283 - Occasional9
HP:0002023HP:0002023Anal atresia0SLX4 CL E G H8446423845ORPHA:84Fanconi anemiaHP:0040283 - Occasional274
HP:0002023HP:0002023Anal atresia0SPINT2 CL E G H1065311247OMIM:270420Diarrhea 3, secretory sodium, congenital, with or without other congenital anomaliesHP:0040283 - Occasional6
HP:0002023HP:0002023Anal atresia0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional32
HP:0002023HP:0002023Anal atresia0TBX3 CL E G H692611602ORPHA:3138Ulnar-mammary syndromeHP:0040283 - Occasional100
HP:0002023HP:0002023Anal atresia0TBX3 CL E G H692611602OMIM:181450Ulnar-Mammary syndrome.100
HP:0002023HP:0002023Anal atresia0TCTN3 CL E G H2612324519ORPHA:2753Orofaciodigital syndrome type 4HP:0040283 - Occasional31
HP:0002023HP:0002023Anal atresia0THOC6 CL E G H7922828369ORPHA:363444THOC6-related developmental delay-microcephaly-facial dysmorphism syndromeHP:0040283 - Occasional1
HP:0002023HP:0002023Anal atresia0TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0002023HP:0002023Anal atresia0TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent12
HP:0002023HP:0002023Anal atresia0TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002023HP:0002023Anal atresia0TNRC6B CL E G H2311229190OMIM:619243GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES; GDSBA
HP:0002023HP:0002023Anal atresia0TWIST1 CL E G H729112428OMIM:617746Sweeney-Cox syndrome.18
HP:0002023HP:0002023Anal atresia0TWIST2 CL E G H11758120670OMIM:227260FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD37
HP:0002023HP:0002023Anal atresia0TWIST2 CL E G H11758120670ORPHA:1807Focal facial dermal dysplasia type IIIHP:0040282 - Frequent7
HP:0002023HP:0002023Anal atresia0UBE2T CL E G H2908925009ORPHA:84Fanconi anemiaHP:0040283 - Occasional2
HP:0002023HP:0002023Anal atresia0UBR1 CL E G H19713116808ORPHA:2315Johanson-Blizzard syndromeHP:0040282 - Frequent25
HP:0002023HP:0002023Anal atresia0UBR1 CL E G H19713116808OMIM:243800Johanson-Blizzard syndrome.25
HP:0002023HP:0002023Anal atresia0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0002023HP:0002023Anal atresia0UPB1 CL E G H5173316297OMIM:613161Beta-Ureidopropionase deficiency44
HP:0002023HP:0002023Anal atresia0USP9X CL E G H823912632OMIM:300968Mental retardation, X-linked 99, syndromic, female-restricted27
HP:0002023HP:0002023Anal atresia0USP9X CL E G H823912632ORPHA:480880X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disabilityHP:0040282 - Frequent27
HP:0002023HP:0002023Anal atresia0VANGL1 CL E G H8183915512ORPHA:3027Caudal regression sequenceHP:0040282 - Frequent111
HP:0002023HP:0002023Anal atresia0WASHC5 CL E G H989728984ORPHA:73C syndromeHP:0040283 - Occasional83
HP:0002023HP:0002023Anal atresia0WASHC5 CL E G H989728984OMIM:220210Ritscher-Schinzel syndrome 1.83
HP:0002023HP:0002023Anal atresia0WDR35 CL E G H5753929250ORPHA:93271Short rib-polydactyly syndrome, Verma-Naumoff typeHP:0040283 - Occasional136
HP:0002023HP:0002023Anal atresia0WNT3 CL E G H747312782OMIM:273395Tetraamelia, autosomal recessive.12
HP:0002023HP:0002023Anal atresia0WNT3 CL E G H747312782ORPHA:3301Tetraamelia-multiple malformations syndromeHP:0040282 - Frequent12
HP:0002023HP:0002023Anal atresia0WNT7A CL E G H747612786ORPHA:2879Phocomelia, Schinzel typeHP:0040283 - Occasional13
HP:0002023HP:0002023Anal atresia0XRCC2 CL E G H751612829ORPHA:84Fanconi anemiaHP:0040283 - Occasional125
HP:0002023HP:0002023Anal atresia0ZIC3 CL E G H754712874OMIM:306955Heterotaxy, visceral, 1, X-linked39
HP:0002023HP:0002023Anal atresia0ZIC3 CL E G H754712874OMIM:314390VACTERL association, X-linked.39


Genes (134) :ABL1 AMER1 AR ARVCF B3GLCT BCOR BRCA1 BRCA2 BRIP1 CAPN15 CCDC22 CCNQ CD19 CD81 CDC45 CDH1 CEP120 CHD7 CHRM3 COMT COX7B CR2 CTNND1 DACT1 DCHS1 DPYS DYNC2H1 DYNC2I1 DYNC2I2 EHMT1 EMC1 EPCAM ERCC4 EXTL3 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FGFR2 FKRP FKTN FOXF1 FRAS1 FREM2 FUZ GATA1 GDF3 GDF6 GLI3 GP1BB GPC3 GPC4 GRIP1 HCCS HIRA HOXD13 HSPA9 ICOS IFT80 INTU IRF2BP2 JMJD1C KDM6A KIF7 KMT2C KMT2D LARGE1 LONP1 MAD2L2 MAMLD1 MED12 MEOX1 MID1 MKKS MKS1 MNX1 MS4A1 MYCN NAA10 NBN NDUFB11 NFKB1 NFKB2 PALB2 PERCC1 PIGN PIGO PITX2 POMT1 POMT2 PPP2R3C PQBP1 PRKCD RAD51 RAD51C RECQL4 RFWD3 RIPK4 RREB1 RSPO2 SALL1 SALL4 SEC24C SIN3A SLX4 SPINT2 TBX1 TBX3 TCTN3 THOC6 TNFRSF13B TNFRSF13C TNFSF12 TNRC6B TWIST1 TWIST2 UBE2T UBR1 UFD1 UPB1 USP9X VANGL1 WASHC5 WDR35 WNT3 WNT7A XRCC2 ZIC3

Diseases (101) :OMIM:617602 OMIM:300373 ORPHA:95706 ORPHA:567 ORPHA:709 OMIM:309800 ORPHA:84 OMIM:605724 OMIM:619318 ORPHA:7 ORPHA:140952 ORPHA:1572 OMIM:617063 ORPHA:1997 OMIM:119580 OMIM:616300 OMIM:214800 OMIM:100100 ORPHA:2970 OMIM:309801 ORPHA:63260 ORPHA:857 OMIM:617466 OMIM:601390 OMIM:222748 OMIM:613091 ORPHA:93271 ORPHA:261652 OMIM:616875 ORPHA:480898 ORPHA:92050 OMIM:617425 OMIM:314390 ORPHA:3412 OMIM:614083 ORPHA:93259 ORPHA:93260 OMIM:236670 OMIM:265380 ORPHA:210122 ORPHA:2052 ORPHA:3027 OMIM:190685 ORPHA:2345 OMIM:146510 ORPHA:672 OMIM:312870 ORPHA:887 OMIM:616854 OMIM:617925 OMIM:147920 OMIM:200990 OMIM:600373 ORPHA:93932 OMIM:305450 ORPHA:2745 OMIM:300000 ORPHA:2473 OMIM:236700 OMIM:249000 OMIM:176450 ORPHA:391641 ORPHA:647 OMIM:251260 ORPHA:2059 ORPHA:280633 OMIM:614080 OMIM:614749 OMIM:180500 OMIM:618419 OMIM:309500 ORPHA:93950 OMIM:617244 OMIM:613390 ORPHA:1225 OMIM:218600 OMIM:263650 ORPHA:3301 OMIM:107480 OMIM:607323 OMIM:147750 ORPHA:2307 ORPHA:94065 OMIM:270420 ORPHA:3138 OMIM:181450 ORPHA:2753 ORPHA:363444 OMIM:619243 OMIM:617746 OMIM:227260 ORPHA:1807 ORPHA:2315 OMIM:243800 OMIM:613161 OMIM:300968 ORPHA:480880 OMIM:220210 OMIM:273395 ORPHA:2879 OMIM:306955
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.